Intraperitoneal injection of galangin can remarkably inhibit the LPS-induced synthesis of IL-6 and TNF-α, the change in lung tissue dry/wet weight ratio, and the disruption of lung tissue structure, improving the survival rate of rats with inflammatory lung injury. The gene discussed is TNF; the disease is injury.